The global hemostasis and tissue sealing agents market size reached US$ 5.92 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 9.28 Billion by 2027, exhibiting a growth rate (CAGR) of 7.60% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Hemostasis is a normal physiological response of the body, which regulates blood fluidity by stopping blood loss from the damaged blood vessel through hemostats. On the other hand, tissue sealing prevents perioperative hemorrhage and controls blood loss from damaged tissues through tissue sealing agents. Hemostats and tissue sealing agents are both used to compress blood vessels and avoid hemorrhage, blood flow, and other fluid discharge. They include thrombin sealant, fibrin glue, bovine serum or albumin, and gelatin matrix. They ensure blood fluidity and blood vessel integrity and help reduce wound healing and operative time, minimize the recovery time and hospital stay and provide better management of anticoagulated patients. They are used to disperse raw surface bleeding, bone bleeding, oozing venous bleeds, and needle-opening bleeding. At present, they are easily available in the market with varying compositions, mechanisms of action, cost, application, and adherence.

Hemostasis and Tissue Sealing Agents Market Trends:
The increasing global geriatric population and chronic medical conditions represent one of the key factors positively influencing the market. The rising participation of individuals in physical activities, along with the increasing occurrence of injuries caused during workouts and sports and physical activities, is catalyzing the demand for hemostasis and tissue sealing agents across the globe. In addition, rising cases of road accidents and gastrointestinal, pulmonary, and cardiovascular surgeries are increasing the demand for hemostats and tissue sealing. Apart from this, shifting consumer preference toward minimally invasive surgeries (MIS) for minimal incision and blood loss and faster recovery time is offering lucrative growth opportunities to manufacturers. Furthermore, leading market players are focusing on the development of multi-usage and ready-to-use products, which is expected to propel market growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global hemostasis and tissue sealing agents market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product type, material type, application and end user.

Breakup by Product Type:

Topical Hemostats
Adhesive and Tissue Sealant

Breakup by Material Type:

Collagen-based
Oxidized Regenerated Cellulose (ORC) based
Gelatin-based
Polysaccharide-based
Others

Breakup by Application:

General Surgery
Minimally Invasive Surgery
Others

Breakup by End User:

Hospitals
Ambulatory Surgical Centers
Home Care Settings
Others

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Advance Medical Solution Group Plc., Artivion Inc., B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson & Company, Integra LifeSciences Corporation, Johnson & Johnson, Medtronic plc, Pfizer Inc., Smith & Nephew plc and Terumo Corporation.

Key questions answered in this report:
How has the global hemostasis and tissue sealing agents market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global hemostasis and tissue sealing agents market?
What are the key regional markets?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the material type?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global hemostasis and tissue sealing agents market and who are the key players?
What is the degree of competition in the industry?